Artificial intelligence, drug repurposing and peer review.

Levin, Jeremy M; Oprea, Tudor I; Davidovich, Sagie; Clozel, Thomas; Overington, John P; Vanhaelen, Quentin; Cantor, Charles R; Bischof, Evelyne; Zhavoronkov, Alex

Levin, Jeremy M; Oprea, Tudor I; Davidovich, Sagie; Clozel, Thomas; Overington, John P; Vanhaelen, Quentin; Cantor, Charles R; Bischof, Evelyne; Zhavoronkov, Alex.

Afiliação

Levin JM; Ovid Therapeutics, Inc, New York, NY, USA.
Oprea TI; Biotechnology Innovation Organization (BIO), Washington, DC, USA.
Davidovich S; Department of Internal Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Clozel T; Autophagy Inflammation and Metabolism Center of Biomedical Research Excellence, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Overington JP; Department of Rheumatology and Inflammation Research, Institute of Medicine, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Vanhaelen Q; Novo Nordisk Foundation Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Cantor CR; SparkBeyond, Netanya, Israel.
Bischof E; Owkin, Paris, France.
Zhavoronkov A; Medicines Discovery Catapult, Cheshire, UK.

Nat Biotechnol ; 38(10): 1127-1131, 2020 10.

Article em En | MEDLINE | ID: mdl-32929264

Assuntos

Inteligência Artificial; Biologia Computacional/tendências; Reposicionamento de Medicamentos/tendências; Pandemias; Humanos; Revisão por Pares; Tratamento Farmacológico da COVID-19

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inteligência Artificial / Biologia Computacional / Reposicionamento de Medicamentos / Pandemias Limite: Humans Idioma: En Revista: Nat Biotechnol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google